Newcells Biotech Ltd

Newcells Biotech builds functional in vitro models to improve clinical translation and drug discovery

[Newcells Biotech Ltd @NewcellsBiotech]

Join Megan Webster, PhD, Principal Scientist, for a talk on Lung Fibrosis at The 3Rs Collaborative (3RsC) webinar next week:

📌 'Utilisation of high-content imaging for the study of lung fibrosis.'

Register here: https://t.co/zoD2EMEv2l

#Lung #Fibrosis #MPS

[Newcells Biotech Ltd @NewcellsBiotech]

Colin Brown, Chief Scientific Officer, and Rhys Powell, Account Manager, are representing #Newcells at the 51st Annual Meeting of the Japanese Society of #Toxicology 🇯🇵

Come and say hi at booth #21! 👋

#JSOT #JSOT2024

[Newcells Biotech Ltd @NewcellsBiotech]

🔬 AAV Vectors in Retinal #GeneTherapy: Insights from Human iPSC-Derived Retinal #Organoids

🧬Our recent study explores the tropism of AAV vectors in photoreceptor-like cells of human iPSC-derived retinal organoids.

Read it here: https://t.co/GnsAvOEqrl

#Newcells

[Newcells Biotech Ltd @NewcellsBiotech]

🔬Unlocking Insights into Fibrosis: The #FMT Assay

This assay provides critical insights into #fibroticdiseases, outlining the importance of using culture conditions that promote fibroblast activation and matrix deposition for accurate #proteindetection: https://t.co/1qV0RXtyVq

[Newcells Biotech Ltd @NewcellsBiotech]

📸 Recap of day three from the Newcells team at #MPSWorldSummit!📍

👂 Overheard by our booth: "Commercially available #retinalorganoids are a must for the industry. An absolute must."

Chat to our wonderful team at booth #63 to find out why!

[Newcells Biotech Ltd @NewcellsBiotech]

🌐 Join our upcoming webinar 🌐

Our experts will delve into strategies for streamlining the clinical development pipeline, with a special focus on retina-related compounds.

📅 June 19th
⏰ 2:00 PM BST

Learn more and register: https://t.co/ZNthIeFlsl

#Newcells #Retina

[Newcells Biotech Ltd @NewcellsBiotech]

Day one at #MPSWorldSummit!📍

Colin Brown, CSO, will present at 10am PDT on Thursday 13th:

📌 Developing predictive in vitro Glomerulus, Proximal Tubule and Loop of Henle renal cell model platforms to investigate the renal uptake and nephrotoxic liability of large molecules.

[Newcells Biotech Ltd @NewcellsBiotech]

Can we speed up #drugdevelopment in #ophthalmology?

Newcells’ iPSC-derived retinal organoids reconstitute the retinal architecture and provide more accurate in vitro to in vivo extrapolation (IVIVE).

Learn more here 👉 https://t.co/Wg44Ty2Prk

#Retina

[Newcells Biotech Ltd @NewcellsBiotech]

🚀 Introducing aProximate

Newcells’ advanced kidney platform revolutionising #drugdevelopment.

☑️ High-throughput #kidney proximal tubule cell model
☑️ Accurate prediction of in vivo outcomes
☑️ Transporter-mediated DDIs & nephrotoxicity data

https://t.co/pygmVDIeRO

#Newcells

[Newcells Biotech Ltd @NewcellsBiotech]

Current preclinical models of the retina have limitations.

Newcells’ advanced retinal organoids and RPE models are 3D, functionally validated & fully characterised.

Learn more about our models. Download our eBook here: https://t.co/Wg44Ty2Prk

#Newcells #Retina #Organoids

[Newcells Biotech Ltd @NewcellsBiotech]

Kidney nephron models: drug transporter interactions & DDIs

With our innovative advanced models, researchers can accurately simulate drug drug interactions & assess their impact on renal function

Understand more: https://t.co/oGvptX6iaa

#Newcells #Kidney #DrugDiscovery

[Newcells Biotech Ltd @NewcellsBiotech]

Drug-induced #nephrotoxicity can be a major hurdle in new drug development

Newcells solution: cutting-edge #kidney toxicity assays for in vitro renal drug safety/efficacy evaluation

Learn how Newcells tailors projects to your needs: https://t.co/J9vb20aShx

#DrugSafety

[Newcells Biotech Ltd @NewcellsBiotech]

Fact File: Newcells retinal organoids

Our eBook discusses iPSC-derived retinal #organoids & pigment epithelium for in vitro #diseasemodelling & preclinical drug testing.

Discover these models & their applications.

Download it here: https://t.co/Wg44Ty2Prk

#Newcells #Retina

[Newcells Biotech Ltd @NewcellsBiotech]

At Newcells, we build in vitro models to de-risk and improve #clinicaltranslation and #drugdiscovery.

Find out more about our Lung Platform capabilities in this video featuring Dr Megan Webster 💡

#Newcells #DrugDiscovery #InVitro #Lung

https://t.co/qQZKEIqxwy

[Newcells Biotech Ltd @NewcellsBiotech]

Delighted to have Amy Mawdesley, Account Manager, representing Newcells at Innovation for Cell and Gene Therapies in Paris yesterday 🇫🇷

Discover our Retinal Pigment Epithelial (RPE) models here: https://t.co/vuvUq9wxnp

#ICGT #CellTherapy #GeneTherapy #Retina

[Newcells Biotech Ltd @NewcellsBiotech]

Colin Brown, Chief Innovation Officer, manning the booth at #TIDESUSA in Boston.

Our team are looking forward to the final day! Stop by Booth #917 to say hi and chat to our experts 👋

#Newcells #InVitro #PredictiveData

[Newcells Biotech Ltd @NewcellsBiotech]

Visual impairment caused by #AMD affects 1 in 3 people over the age of 75 years and more than 8 million people worldwide.

iPSC technology offers the chance to investigate disease mechanisms and evaluate novel therapeutics.

Download our e-book for more: https://t.co/Wg44Ty2Prk

[Newcells Biotech Ltd @NewcellsBiotech]

Are you testing #therapeutic compounds in the #lung? 🫁

Using primary validated models can give you relevant throughput in a multicellular system, which closely reflects the in vivo environment.

Discover more in the new lung eBook: https://t.co/HArAwo30TV

#lungmodels #SAEC

[Newcells Biotech Ltd @NewcellsBiotech]

Dr Colin Brown, Chief Innovation Officer, will be presenting on in vitro renal models at TIDES 2024 in Boston today: https://t.co/16WVpdtiL1

⏰ 5:45 - 6:45 EDT

Download the poster here: https://t.co/G19NIXxsdD

#Newcells #Kidney #KidneyResearch #KidneyHealth #TIDESUSA

[Newcells Biotech Ltd @NewcellsBiotech]

Discover how our retinal platform has become a robust #drugdiscovery asset to provide models and services globally.

Dr Valeria Chichagova, Associate Director of iPSC Technology and Head of #Retina at Newcells can tell you more.

Watch the video below ▶️
https://t.co/l8giATjQ4i